Phase 3 data encouraging
Cyclo Therapeutics Presents Encouraging Preliminary Safety Data From Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (Npc1)
https://www.moomoo.com/t/news/flash/19100681/3FJnV3zjzb
https://www.moomoo.com/t/news/flash/19100681/3FJnV3zjzb
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment